FDA-Device2026-04-08Class IIPROCESSING DEFECT

Burlington Medical Thyroid Shield recalled for attenuation material degradation

OTHERNationwide distributionMedical devices

What this means

Burlington Medical thyroid shields manufactured between January 16, 2025 and January 21, 2026 contain attenuation material that may degrade over time, reducing the shield's protective effectiveness. This affects multiple model numbers and sizes.

  • Check your thyroid shield's model number and manufacturing date against the FDA recall list
  • Contact Burlington Medical or your healthcare provider for instructions on repair, replacement, or return
  • Stop using the shield if you cannot verify it is not affected
The agency's original wording
Hazard

Potential for attenuation degradation over time, decreasing the lifespan.

Intended for
All ages
Illnesses reported
None reported
Sold states
Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.
Affected count
41,962 units
Manufactured in
3 Elmhurst St, Suite 112, Newport News, VA, United States
Products
Burlington Medical, Thyroid Shield.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1753-2026

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime